First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.
- DOI
- 10.1136/bmjgh-2021-008271
- Published
- 2022 May
- Container
- BMJ global health
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjgh-2021-008271,
title = {First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.},
author = {Tsundue T and Namdon T and Tsewang T and Topgyal S and Dolma T and Lhadon D and Choetso T and Woesal T and Yangkyi T and Gupta A and Peters D and Paster Z and Phunkyi D and Sadutshang TD and Chaisson RE and Dorjee K},
year = {2022},
journal = {BMJ global health},
doi = {10.1136/bmjgh-2021-008271},
url = {https://doi.org/10.1136/bmjgh-2021-008271}
}RIS
TY - JOUR TI - First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India. AU - Tsundue T AU - Namdon T AU - Tsewang T AU - Topgyal S AU - Dolma T AU - Lhadon D AU - Choetso T AU - Woesal T AU - Yangkyi T AU - Gupta A AU - Peters D AU - Paster Z AU - Phunkyi D AU - Sadutshang TD AU - Chaisson RE AU - Dorjee K PY - 2022 JO - BMJ global health DO - 10.1136/bmjgh-2021-008271 UR - https://doi.org/10.1136/bmjgh-2021-008271 ER -
APA
T, T., T, N., T, T., S, T., T, D., D, L., T, C., T, W., T, Y., A, G., D, P., Z, P., D, P., TD, S., RE, C., & K, D. (2022). First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.. BMJ global health. https://doi.org/10.1136/bmjgh-2021-008271
Source records
- pubmed · retrieved 2026-09-26T18:50:36.966Z